Easterly Investment Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,268
Closed -$7.59M 201
2025
Q4
$7.59M Buy
+30,268
New +$8.04M 0.47% 60
2023
Q3
Sell
-46,593
Closed -$9.66M 192
2023
Q2
$9.66M Buy
46,593
+23,443
+101% +$4.55M 0.86% 49
2023
Q1
$4.56M Sell
23,150
-62,005
-73% -$12.8M 0.4% 77
2022
Q4
$17.2M Buy
+85,155
New +$16.6M 1.49% 18

Other funds holding LH

Easterly Investment Partners's LH Position: Q1 2026 in Review

Easterly Investment Partners sold out of Labcorp (LH) in Q1 2026, closing a stake of 30,268 shares — an estimated $7.59M sold.

Easterly Investment Partners first reported a position in LH in Q4 2022 and held it in 4 quarters. The position peaked at $17.2M in Q4 2022. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Easterly Investment Partners reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
  • Easterly Investment Partners sold 30,268 Labcorp shares in Q1 2026, an estimated $7.59M.
  • Easterly Investment Partners first reported a position in Labcorp in Q4 2022 and held it in 4 quarters.
  • Easterly Investment Partners's Labcorp position peaked at $17.2M in Q4 2022.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Easterly Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.